Skip to content

Implant Healing Abutment and Chlorhexidine

Effect of the Application of Chlorhexidine in the Pillars of Implant Healing to Prevent Plate Accumulation. Controlled Random Blind Clinical Study.

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03142828
Acronym
CHX-HA
Enrollment
100
Registered
2017-05-05
Start date
2017-04-15
Completion date
2017-11-26
Last updated
2017-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periimplantitis

Keywords

chlorhexidine, dental implant, in-situ drug delivery,

Brief summary

The work hyposesis is based on the application of a chlorhexidine gel against the non-application on the healing abutments in patients who have received a submerged titanium implant to check its effect on healing and prevention of bacterial plaque accumulation during a period of 1 month.

Detailed description

Once the implants are integrated, and given the consent, the patients will be operated to connect the healing abutments as they come from the manufacturer (Mozo Grau, Ticare®). Patients will follow the study protocol in 2 arms. The random distribution is made prior to assignment following the internet program https://www.random.org

Interventions

DRUGChlorhexidine

Healing abutment with Clorhexidine

OTHERPlacebo

Healing abutment without any antiseptic

Sponsors

Universidad de Murcia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Double blindness performed for patients and for statistical analysis

Intervention model description

After the first week, the healling abutment will be randomly distributed in a test group with application of chlorhexidine gel or a control group without the application of the chlorhexidine gel.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Good systemic health status (ASA I or II). * No current pain. * No use of painkillers or Anti-inflammatory drugs in the prior weeks. * Older than 18 years. * Oral hygiene index of ≤ 2 (Löe and Silness). * A minimum of 2 mm of adhered gum. * A minimum of 8 mm of vertical bone. * A minimum of 7 mm of vestibule-lingual bone. * Scheduled to receive a unitary implant. * Willing to participate in this controlled study.

Exclusion criteria

* Pregnant or nursing women. * Use of any type of medication that might affect the perception of pain. * An history of alcohol or drug abuse. * A requirement for guided regeneration or sinus lifting procedures. * Failure to comply with the study protocol.

Design outcomes

Primary

MeasureTime frameDescription
Degree of inflammation1 month after second surgeryDegree of inflammation was measured using a 4-point Likert scaleInflammation 0 = non-inflamed gingiva with pale pink color. Inflammation 1 = erythematous gingiva without bleeding on manipulation. Inflammation 2 = gingiva with slight bleeding during manipulation during unscrewing or screwing of the abutment. Inflammation 3 = gingiva with heavy bleeding during manipulation during unscrewing or screwing of the abutment.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026